Welcome to the N2B inhaler next generation
The new device is an innovative inhaler pump (MDIP) that combines two well-knows technologies: the ultrasonic pump and the Mesh vibrating membrane.
It allows for delivery of an accurate micro-dose of drug, doesn’t need any propellent, and atomizes calibrated particles. The micro-dose (<50 microliters) of the medicament follows the natural Nasal air flow (even reaching the olfactory area), adheres to the mucosa and doesn’t flood the nasal cavity.
Our device allows to tune all features of the inhaler: drug amount, delivery time, jet-speed and particle size. The drug is contained in a disposable cartridge that protects its quality and guarantees a precise dosage.
Welcome to the next generation
Nowadays, intranasal drug delivery is emerging as a reliable method to bypass the blood–brain barrier (BBB) and deliver a wide range of therapeutic agents including small and large molecules…
There are new and innovative inhaler drugs that do not have an appropriate delivery device, the current Inhalation systems, mechanical spray and pressurized metered dose ones, atomize too much liquid and the output mist is too powerful.
The first Nose To Brain soft-mist inhaler
Rhinó Airsystem is a nasal metered dose inhaler capable of delivering micro-doses of medication with an accurate dosage and “soft-mist” output. It’s the ideal device for Nose-to-brain (N2B) therapy, which involves the use of drugs with extremely narrow therapeutic windows, and/or for systemic activity.
Rhinò is a portable battery-powered device. The drug is contained in the disposable cartridge in a precise amount and thoroughly protected from external contamination. The mesh, embedded in the cartridge, creates a low jet speed mist that seamlessly reaches the apex of the nose without affecting the natural air flow.
The most advanced approach to pulmonary drug delivery
Pulmò Airsystem is an advanced mesh nebulizer compatible with our patented disposable cartridge. The contained drug is protected from any form of contamination, and the dosage is accurate.
Pulmò only works when the patient inhales, thus reducing airborne drug pollution. It’s the ideal device for the treatment of conditions such as Cystic Fibrosis, COPD, and Asthma.
Who
Zodiak technologies is an innovative start-up born in 2018 with the ambition to develop novel respiratory devices for drug nebulization. Our mission is to support pharmaceutical research through hi-tech medical devices, capable of disrupting inhalation therapy and improving patients’ lives.
Mission
Zodiak Technologies is a technological boutique, result of the cooperation between multiple skills and experiences, born with the objective of revolutionizing respiratory drug delivery, by creating medical devices specifically tailored for Nose-to-Brain therapy.
Use the form below for any request about our product. We will contact you as soon as possible.